Alternatives to Afinitor If You Can't Fill Your Prescription

Being unable to fill a cancer medication is stressful and potentially dangerous. If you've been prescribed Afinitor (Everolimus) and can't get it — whether because of availability issues, insurance problems, or cost — you need to know your options.

This guide covers what Afinitor does, how it works, and the real alternatives your doctor may consider if you can't fill your prescription. Important: Never switch medications on your own. Always talk to your oncologist or prescribing doctor before making any changes to your treatment.

What Is Afinitor and What Does It Treat?

Afinitor (Everolimus) is an oral medication made by Novartis that belongs to a drug class called mTOR inhibitors. It's FDA-approved for multiple conditions:

Advanced HR+/HER2- breast cancer (with Exemestane, after prior hormonal therapy)
Progressive neuroendocrine tumors (NET) of the pancreas, GI tract, or lungs
Advanced renal cell carcinoma (kidney cancer) after failure of Sunitinib or Sorafenib
Subependymal giant cell astrocytoma (SEGA) with tuberous sclerosis complex (TSC)
Renal angiomyolipoma with TSC
Partial-onset seizures with TSC (Afinitor Disperz)

For a deeper dive, see our complete overview: What Is Afinitor? Uses, Dosage, and What You Need to Know.

How Does Afinitor Work?

Afinitor works by blocking a protein called mTOR (mammalian target of rapamycin). This protein plays a key role in telling cancer cells to grow, divide, and form new blood vessels. By inhibiting mTOR, Afinitor:

Slows or stops tumor growth
Reduces the blood supply to tumors (anti-angiogenesis)
Decreases the ability of tumor cells to take up glucose for energy

Understanding how Afinitor works helps explain why the alternatives below may be appropriate — they target the same or related pathways. For more on the science, read How Does Afinitor Work? Mechanism of Action Explained.

Alternative Medications to Afinitor

The right alternative depends entirely on your specific diagnosis. Here are the most commonly considered options:

1. Generic Everolimus

Before looking at different drugs entirely, the simplest "alternative" may be switching from brand-name Afinitor to generic Everolimus. Generic versions are FDA-approved and therapeutically equivalent. They contain the same active ingredient at the same dose.

The biggest advantage? Price. Brand-name Afinitor costs over $18,000 per month, while generic Everolimus can cost as little as $90 with a GoodRx Gold discount. If your issue is cost or insurance coverage rather than actual drug availability, the generic may be your best bet. See our savings guide for details.

2. Temsirolimus (Torisel)

Temsirolimus is another mTOR inhibitor, making it the closest pharmacologic relative to Afinitor. Key differences:

Administration: Temsirolimus is given as an IV infusion (typically once weekly in a clinic), while Afinitor is an oral tablet taken daily at home
Approved indications: FDA-approved for advanced renal cell carcinoma
Considerations: Because it requires IV infusion, it's less convenient but may be an option when oral Everolimus isn't available or tolerable

Temsirolimus would most likely be considered for patients with renal cell carcinoma who can't access Afinitor.

3. Sunitinib (Sutent)

Sunitinib is a multi-targeted tyrosine kinase inhibitor (TKI) that works differently from Afinitor but treats some of the same cancers. It inhibits multiple pathways that promote tumor growth and blood vessel formation.

Administration: Oral capsule, taken once daily
Approved indications: Advanced renal cell carcinoma, gastrointestinal stromal tumors (GIST), and progressive pancreatic neuroendocrine tumors (PNET)
Considerations: Different side effect profile than Afinitor. Common side effects include fatigue, diarrhea, skin discoloration, and high blood pressure. It's a different drug class, so your doctor would need to determine if switching is appropriate for your cancer type and treatment history.

4. Palbociclib (Ibrance)

For patients with HR+/HER2- breast cancer, Palbociclib is a CDK4/6 inhibitor that may be an alternative to the Afinitor + Exemestane combination. It's one of the most widely prescribed targeted therapies for this type of breast cancer.

Administration: Oral capsule, taken once daily for 21 days of a 28-day cycle
Approved indications: HR+/HER2- advanced or metastatic breast cancer in combination with hormonal therapy
Considerations: Palbociclib works through a completely different mechanism (CDK4/6 inhibition vs. mTOR inhibition). Other CDK4/6 inhibitors include Ribociclib (Kisqali) and Abemaciclib (Verzenio). Your oncologist will consider your treatment history to determine the best option.

5. Sirolimus (Rapamune)

Sirolimus is the original mTOR inhibitor (also called Rapamycin) and is related to Everolimus. While it's primarily FDA-approved for organ transplant rejection prevention, it has been studied in TSC-related conditions.

Administration: Oral tablet or liquid, taken once daily
Considerations: May be considered off-label for some TSC-related indications if Afinitor is unavailable. Sirolimus has a longer half-life and slightly different dosing. Your neurologist would need to make this decision.

Before Switching: Try to Find Afinitor First

Switching medications — especially cancer medications — is a serious decision. Before exploring alternatives, try these steps to find Afinitor:

Search on Medfinder to check real-time pharmacy availability near you
Ask about generic Everolimus — it's the same drug at a fraction of the cost
Contact Novartis Patient Assistance at pap.novartis.com if cost is the issue
Try a different specialty pharmacy — your current one may not stock your specific strength

For more tips, read our guide: How to Find Afinitor in Stock Near You.

Final Thoughts

If you can't fill your Afinitor prescription, don't panic — but don't wait, either. Talk to your doctor about whether generic Everolimus, Temsirolimus, Sunitinib, Palbociclib, or Sirolimus might be appropriate for your specific condition. The right alternative depends on your cancer type, treatment history, and overall health.

And remember: tools like Medfinder can help you find Afinitor in stock before you need to switch to something else entirely. Start there first.

What is the closest alternative to Afinitor?

The closest alternative is generic Everolimus, which contains the same active ingredient as Afinitor and is FDA-approved as therapeutically equivalent. If you need a different drug entirely, Temsirolimus (Torisel) is the most pharmacologically similar option — it's also an mTOR inhibitor but is given by IV infusion rather than orally.

Can I switch from Afinitor to a generic without telling my doctor?

No — you should always talk to your doctor before switching medications, even from brand to generic. While generic Everolimus is therapeutically equivalent to Afinitor, your doctor may need to adjust monitoring or confirm that the switch is appropriate for your specific treatment plan. Your pharmacist may also substitute automatically, but your doctor should be informed.

Are alternatives to Afinitor less expensive?

It depends on the drug. Generic Everolimus can cost as little as $90 per month with discount cards, a massive savings over $18,000+ for brand-name Afinitor. Other alternatives like Sunitinib and Palbociclib are also expensive specialty medications, though their costs vary. Patient assistance programs and copay cards are available for most of these drugs.

What if my insurance won't cover Afinitor or its alternatives?

If insurance denies coverage, your doctor can file an appeal. You can also apply for the Novartis Patient Assistance Foundation (pap.novartis.com), which provides Afinitor at no cost to eligible patients. For alternatives like Palbociclib or Sunitinib, their manufacturers also have patient assistance programs. A social worker at your cancer center can help navigate these options.

Alternatives to Afinitor If You Can't Fill Your Prescription

Updated:

March 25, 2026

Author:

Peter Daggett